Navigation Links
Links Between Prostate Cancer Treatment, Periodontal Disease

Scientists at the University of Pittsburgh School of Dental Medicine have found that men receiving hormone treatments for prostate cancer are much more likely to show// gum disease than men who do not receive hormone treatments for prostate cancer.

Men diagnosed with prostate cancer face a dizzying array of treatment options: radiation, seed radiation (brachytherapy), freezing (cryotherapy), conventional open surgery (radical prostatectomy), minimally invasive surgery (laparoscopic radical prostatectomy), and, in advanced stages, chemotherapy and hormone therapy. At every stage, patients must answer a list of common questions ranging from what is a prostate to which is the best treatment for prostate cancer. Among the critical elements of their decision is evaluation of the experiences relayed in other patient stories.

In recent years, great strides have been made in prostate cancer treatment, especially for localized prostate cancer. However, men with advanced prostate cancer still face a complicated set of treatment decisions largely because treatments for advanced prostate cancer have remained only partly effective and associated with serious side effects.

Hormone treatment of prostate cancer can reduce pain from metastatic prostate cancer. However, especially since the introduction of prostate-specific antigen (PSA) testing, hormone treatment for prostate cancer has been applied also for men without metastatic prostate cancer, which means it has been in use for very long periods. Consequently, doctors are now seeing the long-term complications of prolonged hormone treatment of prostate cancer.

In this month's issue of the Journal of Urology, researchers from the University of Pittsburgh School of Dental Medicine report that prostate cancer patients receiving ADT are three times as likely to show signs of periodontal, or gum disease, as patients who do not receive the therapy.

Says Arnon Krongrad, M D, founder of the Krongrad Institute for laparoscopic prostate cancer surgery and medical advisor to the American Prostate Cancer Initiative: "Advanced prostate cancer is highly problematic and ours tools are limited. As patients consider hormone treatment, they should carefully weigh the potential for side effects. The list is long and includes fatigue, hot flashes, bone loss, and mood changes. The information about periodontal disease is news and, while it needs confirmation, suggests yet one more reason to tread lightly with hormone treatment of prostate cancer. Men need to be aware of prostate cancer generally and the potential ill effects of hormone treatment specifically."

Source: Emediawire/M
'"/>




Related medicine news :

1. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
2. Links between Depression and Migraine
3. Study Links Folic Acid With Increased Birth Weight
4. A Latest Study Links Fish To Stroke
5. Meta Analysis Links Diabetes And Colorectal Cancer
6. Novel Approach to Identify Protein Links with Genetic Disorder
7. UK Biobank Set Up To Understand the Links between Genes, Lifestyle Environment and Illness
8. To Ape or Not To Ape? Bridging Missing Links in Medical Research
9. Acupuncture Links Positively With Fibromyalgia Cure
10. Study Suggests Links Between Diabetes And Multiple Sclerosis
11. Study Links Children Living In Isolated Rural Areas With A Higher Risk Of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... ... ... Elemental LED, a leading U.S. based engineering and technology company that ... honored with Architectural SSL Product Innovation Awards (PIA) for the most innovative ... LED, provides a wide variety of superior quality linear, task, and accent LED lighting ...
(Date:8/17/2017)... ... August 17, 2017 , ... In its just released 2018 ... and Harry Nelson. This is the third consecutive year that Hardiman and Mills have ... were both recognized for expertise in Health Care Law while Mills was recognized in ...
(Date:8/17/2017)... ... August 17, 2017 , ... With the introduction of new devices, ... number of changes to the smartwatch market. As of June 2017, nearly nine percent ... the six months prior. Additionally, according to latest WEAR Report Industry Overview and Forecast ...
(Date:8/17/2017)... ... 17, 2017 , ... Momkus McCluskey Roberts LLC recently announced it ... member of the firm’s Commercial Litigation and Employment Law groups. , Ms. Parks joined ... in matters of employment litigation, commercial litigation and business disputes. Her experience includes all ...
(Date:8/17/2017)... , ... August 17, 2017 , ... ... Business Development Group, a Florida-based oncology business advisor to oncology practices, announced today ... the dollar amount of attributable savings from resolving critical clinical issues that would ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017 Diplomat Pharmacy, Inc. ... Michigan residents. Naloxone ... Flint retail pharmacy, G-3320 Beecher Road. ... the Food and Drug Administration, is intended to block ... slowed breathing, and loss of consciousness. The medication is ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/8/2017)... --   Second-quarter 2017 revenues ... per share from continuing operations ... percent to $110 million ... $161 million Second-quarter 2017 ... increased 8 percent to $0.93 ...
Breaking Medicine Technology: